INSMED Inc

INSM

INSMED Inc

INSM

Insider Sentiment (TTM):

Last Purchase:2025-05-21Last Sale:2026-06-25Shares Purchased (TTM):0Shares Sold (TTM):1,019,847

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:184,723,562Shares Outstanding:215,468,000Institutional Ownership Pct.:85.73%

Earnings Market Reaction:

Filing Date:2026-08-06Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	545	582	510	335	1,284	403	555	461	1,247	596	482	487
Marketable Securities Current	616	641	920	1,345	572	796	879	1,006	0	0	298	299
Accounts Receivable Net Current	215	179	141	65	55	48	52	42	40	37	41	36
Inventory Net	142	133	132	121	108	101	99	98	90	83	83	78
Prepaid Expense And Other Assets Current	116	78	91	66	62	55	37	41	41	43	24	27
Assets Current	1,634	1,613	1,794	1,932	2,082	1,403	1,622	1,650	1,418	759	929	927
Property Plant And Equipment Net	107	103	103	90	90	88	80	75	73	69	65	65
Finance Lease Right Of Use Asset	-	15	16	16	17	18	18	19	20	20	21	22
Operating Lease Right Of Use Asset	13	14	21	11	10	11	17	16	16	17	18	18
Finite Lived Intangible Assets Net	93	96	98	85	56	57	59	60	61	62	64	65
Goodwill	136	136	136	136	136	136	136	136	136	136	136	136
Other Assets	104	99	97	92	89	90	93	97	86	96	97	92
Assets	2,103	2,076	2,265	2,361	2,480	1,803	2,025	2,053	1,810	1,159	1,330	1,325
Liabilities And Stockhold…
Liabilities Current
Accounts Payable And Other Accrued Liabilities Cur…	-	-	-	-	-	-	-	249	291	189	-	188
Long Term Debt Current	-	-	-	-	-	-	-	-	224	224	-	-
Accounts Payable And Accrued Liabilities Current	429	353	456	410	305	233	285	-	-	-	215	-
Finance Lease Liability Current	-	3	3	3	3	3	3	3	3	3	3	3
Operating Lease Liability Current	6	5	9	4	4	4	9	8	6	5	8	6
Liabilities Current	439	361	469	417	312	239	298	259	524	421	226	197
Long Term Debt Noncurrent	544	542	541	540	539	1,105	1,103	955	947	939	1,155	1,148
Accrued Royalties Current And Noncurrent	160	162	163	164	164	163	161	160	158	157	155	153
Business Combination Contingent Consideration Liab…	171	270	314	260	181	160	144	158	102	64	85	70
Finance Lease Liability Noncurrent	-	20	21	22	22	23	24	25	26	26	27	28
Operating Lease Liability Noncurrent	8	10	12	8	8	8	9	10	12	14	11	13
Other Liabilities Noncurrent	6	6	6	6	6	5	0	3	3	3	3	6
Liabilities	1,345	1,371	1,526	1,415	1,230	1,704	1,740	1,570	1,771	1,624	1,662	1,614
Stockholders Equity
Common Stock Value	2	2	2	2	2	2	2	2	2	1	1	1
Additional Paid In Capital	6,572	6,503	6,372	6,250	6,184	4,715	4,646	4,605	3,944	3,139	3,113	2,971
Retained Earnings Accumulated Deficit	-5,813	-5,800	-5,637	-5,308	-4,938	-4,617	-4,360	-4,124	-3,904	-3,603	-3,446	-3,260
Accumulated Other Comprehensive Income Loss Net Of…	-3	0	1	2	2	-1	-2	1	-3	-2	-1	-2
Stockholders Equity	757	705	739	946	1,250	99	285	483	39	-465	-332	-289
Liabilities And Stockholders Equity	2,103	2,076	2,265	2,361	2,480	1,803	2,025	2,053	1,810	1,159	1,330	1,325
Common Stock Par Or Stated Value Per Share	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01
Common Stock Shares Authorized	500	500	500	500	500	500	500	500	500	500	500	500
Common Stock Shares Issued	218	217	214	213	211	182	179	179	167	149	148	143
Shares Outstanding	218	217	214	213	211	182	179	179	167	149	148	143

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	1.82%	-1.54%	1.83%	-	-	-	-	-	-	-	-	-
2025	6.25%	51.59%	58.39%	24.52%	25.37%	46.08%	2.34%	-9.98%	-16.89%	-13.35%	-3.84%	-37.05%
2024	108.68%	153.98%	182.56%	6.49%	0.93%	-1.18%	8.72%	4.70%	7.77%	-8.44%	-17.99%	-22.16%
2023	-	-	-	-	-	-	-2.86%	11.23%	11.39%	-5.27%	0.37%	-4.35%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Liquidity Ratios
Current Ratio	3.72	4.47	3.83	4.63	6.68	5.86	5.45	6.37	2.71	1.80	4.12	4.71
Quick Ratio	3.14	3.88	3.35	4.18	6.13	5.21	4.99	5.83	2.46	1.50	3.64	4.18
Working Capital	1.20B	1.25B	1.33B	1.51B	1.77B	1.16B	1.32B	1.39B	894.03M	337.86M	703.43M	729.85M
Leverage & Debt
Debt to Equity	1.78	1.95	2.06	1.50	0.98	17.18	6.10	3.25	45.63	-3.49	-5.01	-5.58
Interest Coverage TTM	-10.34	-14.00	-14.88	-13.66	-11.76	-11.48	-10.34	-9.82	-9.12	-8.55	-8.69	-8.83
Debt Ratio	0.64	0.66	0.67	0.60	0.50	0.94	0.86	0.76	0.98	1.40	1.25	1.22
Efficiency & Turnover
Asset Turnover TTM	0.50	0.42	0.28	0.20	0.19	0.26	0.22	0.20	0.20	0.24	0.20	0.24
Days Sales Outstanding TTM	43.37	50.39	58.04	43.92	43.70	40.67	46.77	41.45	39.57	39.15	42.40	40.93
Receivables Turnover TTM	8.42	7.24	6.29	8.31	8.35	8.98	7.80	8.81	9.22	9.32	8.61	8.92
Per Share Metrics
Diluted EPS TTM	-4.03	-5.49	-6.42	-5.59	-5.46	-5.60	-5.57	-4.98	-5.19	-5.03	-5.34	-5.06
Free Cash Flow Per Share TTM	-3.72	-4.28	-4.86	-4.28	-4.59	-4.36	-4.30	-3.66	-3.82	-3.96	-3.91	-3.67
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Gross Profit Margin TTM	83.46%	81.81%	79.73%	76.54%	75.72%	76.49%	76.43%	77.25%	77.61%	78.07%	78.52%	78.56%
Operating Profit Margin TTM	-73.89%	-140.56%	-205.59%	-258.92%	-252.41%	-257.43%	-241.47%	-240.88%	-231.39%	-224.08%	-232.51%	-243.16%
Net Profit Margin TTM	-76.94%	-144.44%	-210.54%	-264.83%	-259.82%	-265.93%	-251.24%	-252.01%	-244.27%	-236.74%	-245.59%	-257.69%
Growth Metrics
Net Revenue Growth (1Y)	185.76%	115.09%	66.73%	30.34%	21.15%	20.77%	19.17%	22.13%	21.94%	22.54%	24.39%	15.95%
Net Income Growth (1Y)	-15.38%	16.83%	39.73%	36.97%	28.86%	35.66%	21.91%	19.44%	15.36%	36.62%	55.66%	66.59%
EPS Growth (1Y)	-26.30%	-1.94%	15.17%	12.37%	5.31%	11.36%	4.36%	-1.75%	2.57%	25.49%	36.38%	40.81%
Valuation Metrics
P/E TTM	-26.48	-29.76	-27.13	-25.76	-18.42	-13.62	-12.39	-14.67	-12.91	-5.39	-5.81	-4.99
P/B TTM	30.59	49.99	46.87	32.25	15.24	139.15	39.69	26.23	267.02	-8.67	-13.11	-12.47
P/S TTM	20.37	42.99	57.12	68.22	47.86	36.21	31.14	36.98	31.54	12.77	14.26	12.85
Market Cap	23.17B	35.23B	34.64B	30.50B	19.05B	13.80B	11.33B	12.68B	10.37B	4.03B	4.35B	3.61B
Enterprise Value	23.17B	35.20B	34.67B	30.70B	18.31B	14.50B	11.88B	13.18B	10.29B	4.60B	5.03B	4.27B
Calculated Values
Free Cash Flow TTM	-807.67M	-921.64M	-967.58M	-906.14M	-868.57M	-789.25M	-705.81M	-636.03M	-590.61M	-588.55M	-549.54M	-524.40M
Net Debt	-1.25M	-36.53M	33.86M	208.20M	-742.67M	704.88M	551.31M	496.25M	-72.74M	570.24M	675.55M	662.93M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2026-06-25Sale

Owner: Lewis, William

Title: Chair and CEO

Shares: 21,398

Price/Share: $104.25

Value: $2,230,741.50

Shares Owned: 258,917

Relationship: Director,Officer

Ownership: Direct

2026-06-22Sale

Owner: Smith, Michael Alexander

Title: Chief Legal Officer

Shares: 1,806

Price/Share: $95.82

Value: $173,050.92

Shares Owned: 37,648

Relationship: Officer

Ownership: Direct

2026-06-08Sale

Owner: Lewis, William

Title: Chair and CEO

Shares: 6,515

Price/Share: $94.03

Value: $612,605.45

Shares Owned: 258,917

Relationship: Director,Officer

Ownership: Direct

2026-06-05Sale

Owner: Flammer, Martina M.D.

Title: Chief Medical Officer

Shares: 1,858

Price/Share: $103.78

Value: $192,823.24

Shares Owned: 60,486

Relationship: Officer

Ownership: Direct

2026-06-03Sale

Owner: Lewis, William

Title: Chair and CEO

Shares: 7,605

Price/Share: $102.27

Value: $777,763.35

Shares Owned: 265,432

Relationship: Director,Officer

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2026-06-25	Lewis, William	Director,Officer	Chair and CEO	Direct	Sale	21,398	104.25	$2,230,741.50	258,917	4
2026-06-22	Smith, Michael Alexander	Officer	Chief Legal Officer	Direct	Sale	1,806	95.82	$173,050.92	37,648	4
2026-06-08	Lewis, William	Director,Officer	Chair and CEO	Direct	Sale	6,515	94.03	$612,605.45	258,917	4
2026-06-05	Flammer, Martina M.D.	Officer	Chief Medical Officer	Direct	Sale	1,858	103.78	$192,823.24	60,486	4
2026-06-03	Lewis, William	Director,Officer	Chair and CEO	Direct	Sale	7,605	102.27	$777,763.35	265,432	4
2026-06-03	Bonstein, Sara	Officer	Chief Financial Officer	Direct	Sale	2,404	102.27	$245,857.08	69,082	4
2026-06-03	Smith, Michael Alexander	Officer	Chief Legal Officer	Direct	Sale	2,159	102.27	$220,800.93	39,454	4
2026-06-03	Adsett, Roger	Officer	Chief Operating Officer	Direct	Sale	2,370	102.27	$242,379.90	98,603	4
2026-05-22	Smith, Michael Alexander	Officer	Chief Legal Officer	Direct	Sale	6,149	108.47	$666,982.03	41,613	4
2026-05-18	Lewis, William	Director,Officer	Chair and CEO	Direct	Sale	25,564	106.23	$2,715,663.72	273,037	4
2026-05-14	Flammer, Martina M.D.	Officer	Chief Medical Officer	Direct	Sale	10,479	117.54	$1,231,701.66	64,910	4
2026-05-13	Smith, Michael Alexander	Officer	Chief Legal Officer	Direct	Sale	4,109	116.18	$477,383.62	47,762	4
2026-05-13	Bonstein, Sara	Officer	Chief Financial Officer	Direct	Sale	8,272	116.18	$961,040.96	71,486	4
2026-05-13	Adsett, Roger	Officer	Chief Operating Officer	Direct	Sale	5,837	116.18	$678,142.66	100,973	4
2026-05-13	Lewis, William	Director,Officer	Chair and CEO	Direct	Sale	13,283	116.18	$1,543,218.94	287,902	4
2026-05-11	Flammer, Martina M.D.	Officer	Chief Medical Officer	Direct	Sale	12,949	100.76	$1,304,741.24	83,243	4
2026-05-04	Lewis, William	Director,Officer	Chair and CEO	Direct	Sale	10,699	137.15	$1,467,367.85	301,185	4
2026-04-16	Lewis, William	Director,Officer	Chair and CEO	Direct	Sale	10,699	144.31	$1,543,972.69	301,185	4
2026-04-06	Lewis, William	Director,Officer	Chair and CEO	Direct	Sale	10,699	162.99	$1,743,830.01	301,185	4
2026-04-01	Adsett, Roger	Officer	Chief Operating Officer	Direct	Sale	88,060	164.08	$14,448,884.80	106,810	4
2026-03-30	Smith, Michael Alexander	Officer	Chief Legal Officer	Direct	Sale	19,638	150.98	$2,964,945.24	51,871	4
2026-03-19	Lewis, William	Director,Officer	Chair and CEO	Direct	Sale	10,699	143.23	$1,532,417.77	301,185	4
2026-03-05	Lewis, William	Director,Officer	Chair and CEO	Direct	Sale	10,699	145.93	$1,561,305.07	301,185	4
2026-02-24	Smith, Michael Alexander	Officer	Chief Legal Officer	Direct	Sale	24,774	155.17	$3,844,181.58	51,871	4
2026-02-19	Lewis, William	Director,Officer	Chair and CEO	Direct	Sale	10,699	151.14	$1,617,046.86	301,185	4
2026-02-09	Lewis, William	Director,Officer	Chair and CEO	Direct	Sale	13,396	148.01	$1,982,741.96	301,185	4
2026-02-05	Flammer, Martina M.D.	Officer	Chief Medical Officer	Direct	Sale	869	152.44	$132,470.36	83,243	4
2026-02-03	Bonstein, Sara	Officer	Chief Financial Officer	Direct	Sale	748	156.34	$116,942.32	79,758	4
2026-02-03	Smith, Michael Alexander	Officer	Chief Legal Officer	Direct	Sale	640	156.27	$100,012.80	56,397	4
2026-02-03	Lewis, William	Director,Officer	Chair and CEO	Direct	Sale	3,009	156.34	$470,427.06	303,882	4
2026-02-03	Flammer, Martina M.D.	Officer	Chief Medical Officer	Direct	Sale	795	155.77	$123,837.15	84,112	4
2026-02-03	Adsett, Roger	Officer	Chief Operating Officer	Direct	Sale	791	156.17	$123,530.47	106,810	4
2026-01-20	Lewis, William	Director,Officer	Chair and CEO	Direct	Sale	10,699	158.94	$1,700,499.06	306,891	4
2026-01-12	Lewis, William	Director,Officer	Chair and CEO	Direct	Sale	19,215	170.67	$3,279,424.05	306,891	4
2026-01-09	Flammer, Martina M.D.	Officer	Chief Medical Officer	Direct	Sale	1,887	186.19	$351,340.53	84,907	4
2026-01-08	Bonstein, Sara	Officer	Chief Financial Officer	Direct	Sale	1,447	174.17	$252,023.99	80,506	4
2026-01-08	Smith, Michael Alexander	Officer	Chief Legal Officer	Direct	Sale	1,053	174.17	$183,401.01	57,037	4
2026-01-08	Lewis, William	Director,Officer	Chair and CEO	Direct	Sale	3,223	174.17	$561,349.91	315,407	4
2026-01-08	Adsett, Roger	Officer	Chief Operating Officer	Direct	Sale	2,059	174.17	$358,616.03	107,601	4
2026-01-08	Flammer, Martina M.D.	Officer	Chief Medical Officer	Direct	Sale	4,911	174.02	$854,612.22	86,794	4
2026-01-05	Flammer, Martina M.D.	Officer	Chief Medical Officer	Direct	Sale	12,303	172.35	$2,120,422.05	94,754	4
2026-01-02	Schaeffer, Orlov S Nicole	Officer	Chief People Strategy Officer	Direct	Sale	87,290	176.10	$15,371,769.00	41,754	4
2025-12-18	Lewis, William	Director,Officer	Chair and CEO	Direct	Sale	10,699	166.84	$1,785,021.16	303,911	4
2025-12-05	Sharoky, Melvin Md	Director	-	Direct	Sale	20,000	205.01	$4,100,200.00	243,948	4
2025-12-04	Lewis, William	Director,Officer	Chair and CEO	Direct	Sale	10,699	206.05	$2,204,528.95	303,911	4
2025-12-01	Flammer, Martina M.D.	Officer	Chief Medical Officer	Direct	Sale	8,895	206.91	$1,840,464.45	83,111	4
2025-11-24	Anderson, Elizabeth M	Director	-	Direct	Sale	5,000	204.58	$1,022,900.00	58,729	4
2025-11-17	Lee, Leo	Director	-	Direct	Sale	75,000	195.48	$14,661,000.00	54,677	4
2025-11-14	Anderson, Elizabeth M	Director	-	Direct	Sale	10,000	195.87	$1,958,700.00	63,729	4
2025-11-12	Schaeffer, Orlov S Nicole	Officer	Chief People Strategy Officer	Direct	Sale	30,000	194.10	$5,823,000.00	36,461	4
2025-11-11	Flammer, Martina M.D.	Officer	Chief Medical Officer	Direct	Sale	31,226	189.78	$5,926,070.28	83,111	4
2025-11-03	Smith, Michael Alexander	Officer	Chief Legal Officer	Direct	Sale	27,130	184.42	$5,003,314.60	54,902	4
2025-09-12	Sharoky, Melvin Md	Director	-	Direct	Sale	10,000	145.39	$1,453,900.00	262,675	4
2025-09-12	Schaeffer, Orlov S Nicole	Officer	Chief People Strategy Officer	Direct	Sale	76,520	146.07	$11,177,276.40	36,461	4
2025-09-02	Flammer, Martina M.D.	Officer	Chief Medical Officer	Direct	Sale	186,648	143.65	$26,811,985.20	83,111	4
2025-09-02	Smith, Michael Alexander	Officer	Chief Legal Officer	Direct	Sale	24,272	143.60	$3,485,459.20	54,902	4
2025-08-20	Sharoky, Melvin Md	Director	-	Direct	Sale	10,000	129.50	$1,295,000.00	274,516	4
2025-08-19	Adsett, Roger	Officer	Chief Operating Officer	Direct	Sale	25,000	127.84	$3,196,000.00	105,637	4
2025-08-18	Lewis, William	Director,Officer	Chair and CEO	Indirect	Sale	6,865	128.61	$882,907.65	233,924	4
2025-08-14	Schaeffer, Orlov S Nicole	Officer	Chief People Strategy Officer	Direct	Sale	10,000	127.48	$1,274,800.00	79,764	4
2025-08-12	Sharoky, Melvin Md	Director	-	Direct	Sale	10,000	121.58	$1,215,800.00	290,616	4
2025-08-04	Lewis, William	Director,Officer	Chair and CEO	Indirect	Sale	6,830	109.80	$749,934.00	233,924	4
2025-08-04	Flammer, Martina M.D.	Officer	Chief Medical Officer	Direct	Sale	8,715	109.50	$954,292.50	83,111	4
2025-07-21	Bonstein, Sara	Officer	Chief Financial Officer	Direct	Sale	58,400	102.70	$5,997,680.00	73,505	4
2025-07-15	Smith, Michael Alexander	Officer	Chief Legal Officer	Direct	Sale	933	102.51	$95,641.83	66,394	4
2025-07-15	Lewis, William	Director,Officer	Chair and CEO	Indirect	Sale	6,830	102.56	$700,484.80	233,924	4
2025-07-07	Bonstein, Sara	Officer	Chief Financial Officer	Direct	Sale	57,764	95.92	$5,540,722.88	84,017	4
2025-07-01	Lewis, William	Director,Officer	Chair and CEO	Indirect	Sale	6,830	98.72	$674,257.60	233,924	4
2025-06-23	Bonstein, Sara	Officer	Chief Financial Officer	Direct	Sale	57,765	101.93	$5,887,986.45	93,536	4
2025-06-16	Lewis, William	Director,Officer	Chair and CEO	Direct	Sale	5,204	100.06	$520,712.24	303,554	4
2025-06-16	Adsett, Roger	Officer	Chief Operating Officer	Direct	Sale	10,686	98.91	$1,056,952.26	130,637	4
2025-06-11	Flammer, Martina M.D.	Officer	Chief Medical Officer	Direct	Sale	19,423	94.50	$1,835,473.50	83,111	4
2025-06-11	Schaeffer, Orlov S Nicole	Officer	Chief People Strategy Officer	Direct	Sale	99,172	93.88	$9,310,267.36	89,407	4
2025-06-10	Bonstein, Sara	Officer	Chief Financial Officer	Direct	Sale	57,766	89.47	$5,168,324.02	103,412	4
2025-06-05	Smith, Michael Alexander	Officer	Chief Legal Officer	Direct	Sale	1,879	73.50	$138,106.50	67,718	4
2025-06-04	Mcgirr, David W J	Director	-	Direct	Sale	3,000	73.27	$219,810.00	97,723	4
2025-06-03	Adsett, Roger	Officer	Chief Operating Officer	Direct	Sale	1,860	71.50	$132,990.00	141,323	4
2025-06-03	Lewis, William	Director,Officer	Chair and CEO	Direct	Sale	5,472	71.50	$391,248.00	308,758	4
2025-06-03	Bonstein, Sara	Officer	Chief Financial Officer	Direct	Sale	1,579	71.50	$112,898.50	113,288	4
2025-06-03	Flammer, Martina M.D.	Officer	Chief Medical Officer	Direct	Sale	1,686	71.50	$120,549.00	83,111	4
2025-06-03	Smith, Michael Alexander	Officer	Chief Legal Officer	Direct	Sale	1,448	71.50	$103,532.00	69,597	4
2025-06-03	Schaeffer, Orlov S Nicole	Officer	Chief People Strategy Officer	Direct	Sale	1,642	71.50	$117,403.00	118,579	4
2025-05-30	Smith, Michael Alexander	Officer	Chief Legal Officer	Direct	Sale	26,327	69.28	$1,823,934.56	71,045	4
2025-05-21	Desjardins, Clarissa	Director	-	Indirect	Purchase	1,130	66.35	$74,975.50	3,025	4
2025-05-20	Lewis, William	Director,Officer	Chair and CEO	Direct	Sale	21,057	67.77	$1,427,032.89	314,230	4
2025-05-16	Flammer, Martina M.D.	Officer	Chief Medical Officer	Direct	Sale	1,799	67.53	$121,486.47	84,797	4
2025-05-14	Flammer, Martina M.D.	Officer	Chief Medical Officer	Direct	Sale	1,744	65.61	$114,423.84	90,013	4
2025-05-14	Schaeffer, Orlov S Nicole	Officer	Chief People Strategy Officer	Direct	Sale	1,236	65.61	$81,093.96	114,643	4
2025-05-14	Lewis, William	Director,Officer	Chair and CEO	Direct	Sale	3,771	65.61	$247,415.31	312,973	4
2025-05-14	Smith, Michael Alexander	Officer	Chief Legal Officer	Direct	Sale	409	65.61	$26,834.49	91,794	4
2025-05-14	Adsett, Roger	Officer	Chief Operating Officer	Direct	Sale	1,925	65.61	$126,299.25	136,675	4
2025-05-14	Bonstein, Sara	Officer	Chief Financial Officer	Direct	Sale	1,634	65.61	$107,206.74	108,359	4
2025-05-01	Lewis, William	Director,Officer	Chair and CEO	Indirect	Sale	6,830	72.51	$495,243.30	233,924	4
2025-04-15	Lewis, William	Director,Officer	Chair and CEO	Indirect	Sale	6,830	70.49	$481,446.70	233,924	4
2025-04-01	Lewis, William	Director,Officer	Chair and CEO	Indirect	Sale	6,830	73.94	$505,010.20	233,924	4
2025-03-17	Lewis, William	Director,Officer	Chair and CEO	Direct	Sale	18,750	76.86	$1,441,125.00	334,186	4
2025-03-03	Lewis, William	Director,Officer	Chair and CEO	Direct	Sale	18,750	78.59	$1,473,562.50	334,186	4
2025-02-18	Bonstein, Sara	Officer	Chief Financial Officer	Direct	Sale	18,322	80.64	$1,477,486.08	118,863	4
2025-02-18	Lewis, William	Director,Officer	Chair and CEO	Direct	Sale	18,750	80.90	$1,516,875.00	334,186	4
2025-02-12	Bonstein, Sara	Officer	Chief Financial Officer	Direct	Sale	5,019	80.00	$401,520.00	137,185	4
2025-02-10	Flammer, Martina M.D.	Officer	Chief Medical Officer	Direct	Sale	37,828	78.24	$2,959,662.72	100,165	4
2025-02-10	Adsett, Roger	Officer	Chief Operating Officer	Direct	Sale	42,975	78.24	$3,362,364.00	146,082	4
2025-02-07	Wise, John Drayton	Officer	Chief Commercial Officer	Direct	Sale	10	78.91	$789.10	133,015	4
2025-02-07	Flammer, Martina M.D.	Officer	Chief Medical Officer	Direct	Sale	60	79.59	$4,775.40	137,993	4
2025-02-07	Adsett, Roger	Officer	Chief Operating Officer	Direct	Sale	100	79.57	$7,957.00	189,057	4
2025-02-06	Schaeffer, Orlov S Nicole	Officer	Chief People Strategy Officer	Direct	Sale	23,500	80.90	$1,901,150.00	120,878	4
2025-02-06	Bonstein, Sara	Officer	Chief Financial Officer	Direct	Sale	28,390	80.90	$2,296,751.00	155,506	4
2025-02-06	Lewis, William	Director,Officer	Chair and CEO	Direct	Sale	79,350	80.90	$6,419,415.00	453,894	4
2025-02-06	Smith, Michael Alexander	Officer	Chief Legal Officer	Direct	Sale	20,650	80.90	$1,670,585.00	96,610	4
2025-02-03	Lewis, William	Director,Officer	Chair and CEO	Direct	Sale	18,750	77.00	$1,443,750.00	379,534	4
2025-01-30	Schaeffer, Orlov S Nicole	Officer	Chief People Strategy Officer	Direct	Sale	91,140	80.00	$7,291,200.00	97,083	4
2025-01-15	Lewis, William	Director,Officer	Chair and CEO	Direct	Sale	31,805	70.25	$2,234,301.25	379,534	4
2025-01-14	Flammer, Martina M.D.	Officer	Chief Medical Officer	Direct	Sale	1,384	68.72	$95,108.48	100,165	4
2025-01-14	Adsett, Roger	Officer	Chief Operating Officer	Direct	Sale	1,457	68.72	$100,125.04	146,082	4
2025-01-14	Schaeffer, Orlov S Nicole	Officer	Chief People Strategy Officer	Direct	Sale	872	68.72	$59,923.84	97,083	4
2025-01-10	Adsett, Roger	Officer	Chief Operating Officer	Direct	Sale	4,902	63.74	$312,453.48	147,539	4
2025-01-10	Flammer, Martina M.D.	Officer	Chief Medical Officer	Direct	Sale	6,172	63.68	$393,032.96	101,549	4
2025-01-10	Bonstein, Sara	Officer	Chief Financial Officer	Direct	Sale	1,066	63.72	$67,925.52	118,863	4
2025-01-10	Wise, John Drayton	Officer	Chief Commercial Officer	Direct	Sale	287	65.40	$18,769.80	125,562	4
2025-01-10	Schaeffer, Orlov S Nicole	Officer	Chief People Strategy Officer	Direct	Sale	4,057	63.74	$258,593.18	97,955	4
2025-01-10	Smith, Michael Alexander	Officer	Chief Legal Officer	Direct	Sale	319	63.38	$20,218.22	69,965	4
2025-01-07	Lewis, William	Director,Officer	Chair and CEO	Direct	Sale	8,218	66.02	$542,552.36	376,742	4
2025-01-02	Lewis, William	Director,Officer	Chair and CEO	Direct	Sale	18,750	69.84	$1,309,500.00	384,960	4
2024-12-19	Lewis, William	Director,Officer	Chair and CEO	Direct	Sale	18,750	70.09	$1,314,187.50	384,960	4
2024-12-12	Lewis, William	Director,Officer	Chair and CEO	Direct	Sale	18,750	73.46	$1,377,375.00	384,960	4
2024-09-16	Flammer, Martina M.D.	Officer	Chief Medical Officer	Direct	Sale	13,436	74.92	$1,006,625.12	106,134	4
2024-09-13	Smith, Michael Alexander	Officer	Chief Legal Officer	Direct	Sale	27,871	74.46	$2,075,274.66	67,856	4
2024-09-10	Schaeffer, Orlov S Nicole	Officer	Chief People Strategy Officer	Direct	Sale	37,575	71.62	$2,691,121.50	100,100	4
2024-09-06	Flammer, Martina M.D.	Officer	Chief Medical Officer	Direct	Sale	149,002	71.65	$10,675,993.30	106,134	4
2024-08-12	Schaeffer, Orlov S Nicole	Officer	Chief People Strategy Officer	Direct	Sale	9,469	72.49	$686,407.81	100,100	4
2024-08-12	Smith, Michael Alexander	Officer	Chief Legal Officer	Direct	Sale	88,070	73.20	$6,446,724.00	88,727	4
2024-06-10	Flammer, Martina M.D.	Officer	Chief Medical Officer	Direct	Sale	21,195	60.00	$1,271,700.00	106,134	4
2024-06-03	Schaeffer, Orlov S Nicole	Officer	Chief People Strategy Officer	Direct	Sale	55,000	55.33	$3,043,150.00	108,760	4
2024-05-30	Flammer, Martina M.D.	Officer	Chief Medical Officer	Direct	Sale	21,195	55.00	$1,165,725.00	106,134	4
2024-05-29	Bonstein, Sara	Officer	Chief Financial Officer	Direct	Sale	220,564	50.00	$11,028,200.00	117,481	4
2024-05-28	Smith, Michael Alexander	Officer	Chief Legal Officer	Direct	Sale	44,722	49.53	$2,215,080.66	88,828	4
2024-05-28	Schaeffer, Orlov S Nicole	Officer	Chief People Strategy Officer	Direct	Sale	27,500	49.53	$1,362,075.00	108,760	4
2024-05-28	Wise, John Drayton	Officer	Chief Commercial Officer	Direct	Sale	7,852	49.48	$388,516.96	121,657	4
2024-05-17	Flammer, Martina M.D.	Officer	Chief Medical Officer	Direct	Sale	4,642	25.09	$116,467.78	106,134	4
2024-05-17	Adsett, Roger	Officer	Chief Operating Officer	Direct	Sale	5,945	25.09	$149,160.05	149,275	4
2024-05-14	Wise, John Drayton	Officer	Chief Commercial Officer	Direct	Sale	5,088	25.47	$129,591.36	123,259	4
2024-05-14	Lewis, William	Director,Officer	Chair and CEO	Direct	Sale	22,198	25.52	$566,492.96	384,125	4
2024-05-14	Schaeffer, Orlov S Nicole	Officer	Chief People Strategy Officer	Direct	Sale	6,508	25.53	$166,149.24	108,760	4
2024-05-14	Adsett, Roger	Officer	Chief Operating Officer	Direct	Sale	7,857	25.50	$200,353.50	155,220	4
2024-05-14	Bonstein, Sara	Officer	Chief Financial Officer	Direct	Sale	11,088	25.32	$280,748.16	117,481	4
2024-05-14	Smith, Michael Alexander	Officer	Chief Legal Officer	Direct	Sale	5,093	25.40	$129,362.20	94,579	4
2024-05-14	Flammer, Martina M.D.	Officer	Chief Medical Officer	Direct	Sale	10,640	25.47	$271,000.80	110,776	4
2024-01-12	Flammer, Martina M.D.	Officer	Chief Medical Officer	Direct	Sale	4,667	28.63	$133,616.21	106,898	4
2024-01-12	Adsett, Roger	Officer	Chief Operating Officer	Direct	Sale	5,251	28.63	$150,336.13	148,559	4
2024-01-10	Adsett, Roger	Officer	Chief Operating Officer	Direct	Sale	3,536	28.90	$102,190.40	153,810	4
2024-01-10	Flammer, Martina M.D.	Officer	Chief Medical Officer	Direct	Sale	1,245	28.90	$35,980.50	111,565	4
2024-01-09	Smith, Michael Alexander	Officer	General Counsel, Senior VP	Direct	Sale	2,373	28.76	$68,247.48	86,364	4
2024-01-09	Wise, John Drayton	Officer	Chief Commercial Officer	Direct	Sale	1,861	28.78	$53,559.58	113,829	4
2024-01-09	Bonstein, Sara	Officer	Chief Financial Officer	Direct	Sale	4,497	29.18	$131,222.46	114,051	4
2024-01-09	Schaeffer, Orlov S Nicole	Officer	Chief People Strategy Officer	Direct	Sale	3,668	29.15	$106,922.20	101,984	4
2024-01-08	Lewis, William	Director,Officer	Chair and CEO	Direct	Sale	45,120	29.49	$1,330,588.80	373,538	4
2024-01-05	Wise, John Drayton	Officer	Chief Commercial Officer	Direct	Sale	1,167	29.32	$34,216.44	115,690	4
2024-01-05	Flammer, Martina M.D.	Officer	Chief Medical Officer	Direct	Sale	1,386	29.21	$40,485.06	117,525	4
2024-01-05	Lewis, William	Director,Officer	Chair and CEO	Direct	Sale	6,979	29.26	$204,205.54	373,538	4
2024-01-05	Schaeffer, Orlov S Nicole	Officer	Chief People Strategy Officer	Direct	Sale	1,457	29.28	$42,660.96	105,149	4
2024-01-05	Adsett, Roger	Officer	Chief Operating Officer	Direct	Sale	3,042	29.21	$88,856.82	161,183	4
2024-01-05	Smith, Michael Alexander	Officer	General Counsel, Senior VP	Direct	Sale	627	29.31	$18,377.37	88,737	4
2023-12-28	Schaeffer, Orlov S Nicole	Officer	Chief People Strategy Officer	Direct	Sale	22,288	32.00	$713,216.00	94,549	4
2023-12-22	Bonstein, Sara	Officer	Chief Financial Officer	Direct	Sale	13,199	30.00	$395,970.00	105,241	4
2023-12-22	Flammer, Martina M.D.	Officer	Chief Medical Officer	Direct	Sale	28,310	30.00	$849,300.00	106,038	4
2023-10-27	Lewis, William	Director,Officer	Chair and CEO	Indirect	Sale	112,000	25.04	$2,804,480.00	0	4
2023-07-11	Smith, Michael Alexander	Officer	General Counsel, Senior VP	Direct	Sale	740	20.18	$14,933.20	77,142	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

85.73%

Inst. Shares: 184,723,562

Shares Outstanding: 215,468,000

2025-12-31

102.23%

Inst. Shares: 203,446,545

Shares Outstanding: 199,014,000

2025-09-30

93.14%

Inst. Shares: 197,240,467

Shares Outstanding: 211,759,000

2025-06-30

100.52%

Inst. Shares: 190,281,687

Shares Outstanding: 189,302,000

2025-03-31

97.08%

Inst. Shares: 175,578,367

Shares Outstanding: 180,860,000

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	184,723,562	215,468,000	85.73%
2025-12-31	203,446,545	199,014,000	102.23%
2025-09-30	197,240,467	211,759,000	93.14%
2025-06-30	190,281,687	189,302,000	100.52%
2025-03-31	175,578,367	180,860,000	97.08%
2024-12-31	170,833,592	164,043,000	104.14%
2024-09-30	165,311,801	173,721,000	95.16%
2024-06-30	156,040,564	154,702,000	100.87%
2024-03-31	129,060,072	148,456,000	86.93%
2023-12-31	127,297,122	140,433,000	90.65%
2023-09-30	121,719,102	142,899,000	85.18%
2023-06-30	121,591,748	137,553,000	88.40%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

INSMED Inc (INSM) — SEC Financial Statements & Analysis

INSMED Inc (INSM) is a pharmaceutical preparations company, incorporated in VA. INSMED Inc trades on Nasdaq as: INSM. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), INSMED Inc reported a 185.76% year-over-year revenue growth, a Gross Profit Margin of 83.46% (TTM), a Debt-to-Equity ratio of 1.78x, a Price-to-Sales (P/S) ratio of 20.37x (TTM), a Price-to-Book (P/B) ratio of 30.59x (TTM), at a market cap of $23.17B. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: 185.76%
Gross Profit Margin TTM: 83.46%
Debt To Equity: 1.78x
P/S TTM: 20.37x
P/B TTM: 30.59x
Market Cap: $23.17B

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is INSMED Inc in?

INSMED Inc (INSM) operates in the Pharmaceutical Preparations industry.

What is INSM's market cap?

INSMED Inc (INSM) has a market capitalization of $23.17B as of 2026-06-30.

What exchange does INSM trade on?

INSMED Inc (INSM) trades on the Nasdaq.

Where is INSMED Inc incorporated?

INSMED Inc is incorporated in VA.

INSMED Inc

Financial Statements

Custom Table

Interactive Financial Visualizations

Earnings Market Reaction

Performance and Valuation Metrics

Insider Transactions

Institutional Ownership

INSMED Inc (INSM) — SEC Financial Statements & Analysis

Frequently Asked Questions

Companies in Pharmaceutical Preparations

Wall Street's data.
Main Street's price.

INSMED Inc (INSM) — SEC Financial Statements & Analysis

Frequently Asked Questions

Companies in Pharmaceutical Preparations

Wall Street's data.Main Street's price.

Wall Street's data.
Main Street's price.